SAGE Therapeutics Inc (NASDAQ:SAGE)

Delayed Data
As of Dec 03
 -1.23 / -3.21%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for SAGE Therapeutics Inc have a median target of 65.50, with a high estimate of 174.00 and a low estimate of 44.00. The median estimate represents a +76.36% increase from the last price of 37.14.

Analyst Recommendations

The current consensus among 22 polled investment analysts is to Buy stock in SAGE Therapeutics Inc. This rating has held steady since November, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.78%
Growthannually -168.32%


Growthquarterly 39.17%
Growthannually -99.41%
Key to the earnings and sales forecast charts.